2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide

C40H41N7O6S — CID 139947456

IUPAC2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide
SMILESCCNC(=O)C[C@@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(CNS(=O)(=O)c4ccc(-c5ccccc5)cc4)nc32)[C@H](O)[C@@H]1O
InChIInChI=1S/C40H41N7O6S/c1-2-41-34(48)22-32-36(49)37(50)40(53-32)47-25-43-35-38(42-23-31(28-14-8-4-9-15-28)29-16-10-5-11-17-29)45-33(46-39(35)47)24-44-54(51,52)30-20-18-27(19-21-30)26-12-6-3-7-13-26/h3-21,25,31-32,36-37,40,44,49-50H,2,22-24H2,1H3,(H,41,48)(H,42,45,46)/t32-,36+,37+,40+/m0/s1
InChIKeyKMULWJHTLDITFO-RUUIWEBLSA-N
MW747.88 g/mol
LogP4.36
Rot. Bonds14

About 2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide

2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide (PubChem CID 139947456) has the molecular formula C40H41N7O6S and a molecular weight of 747.88 g/mol. Its IUPAC name is 2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide.

Molecular Properties

Compound Name2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide
PubChem CID139947456
Molecular FormulaC40H41N7O6S
Molecular Weight747.88 g/mol
Exact Mass747.28
IUPAC Name2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide
SMILESCCNC(=O)C[C@@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(CNS(=O)(=O)c4ccc(-c5ccccc5)cc4)nc32)[C@H](O)[C@@H]1O
InChIInChI=1S/C40H41N7O6S/c1-2-41-34(48)22-32-36(49)37(50)40(53-32)47-25-43-35-38(42-23-31(28-14-8-4-9-15-28)29-16-10-5-11-17-29)45-33(46-39(35)47)24-44-54(51,52)30-20-18-27(19-21-30)26-12-6-3-7-13-26/h3-21,25,31-32,36-37,40,44,49-50H,2,22-24H2,1H3,(H,41,48)(H,42,45,46)/t32-,36+,37+,40+/m0/s1
InChIKeyKMULWJHTLDITFO-RUUIWEBLSA-N
XLogP4.36
TPSA180.59 Ų
H-Bond Donors5
H-Bond Acceptors11
Rotatable Bonds14
Heavy Atoms54
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500747.88
LogP ≤ 54.36
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1011

Analyze 2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide?
The IUPAC name of 2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide (CID 139947456) is 2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide.
What is the SMILES notation for 2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide?
The canonical SMILES for 2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide is CCNC(=O)C[C@@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(CNS(=O)(=O)c4ccc(-c5ccccc5)cc4)nc32)[C@H](O)[C@@H]1O.
What is the InChIKey of 2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide?
The InChIKey is KMULWJHTLDITFO-RUUIWEBLSA-N. The full InChI is InChI=1S/C40H41N7O6S/c1-2-41-34(48)22-32-36(49)37(50)40(53-32)47-25-43-35-38(42-23-31(28-14-8-4-9-15-28)29-16-10-5-11-17-29)45-33(46-39(35)47)24-44-54(51,52)30-20-18-27(19-21-30)26-12-6-3-7-13-26/h3-21,25,31-32,36-37,40,44,49-50H,2,22-24H2,1H3,(H,41,48)(H,42,45,46)/t32-,36+,37+,40+/m0/s1.
What are the key properties of 2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide?
2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide has a molecular weight of 747.88 g/mol, XLogP of 4.36, 14 rotatable bonds, 5 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(2S,3S,4R,5R)-5-[6-(2,2-diphenylethylamino)-2-[[(4-phenylphenyl)sulfonylamino]methyl]purin-9-yl]-3,4-dihydroxyoxolan-2-yl]-N-ethylacetamide is sourced from PubChem (CID 139947456), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).